SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 351 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $23,637,416 | +8773.0% | 138,644 | +7208.6% | 2.77% | +4600.0% |
| Q3 2020 | $266,396 | -97.7% | 1,897 | -97.4% | 0.06% | -96.3% |
| Q2 2020 | $11,501,349 | +18.8% | 71,731 | -4.4% | 1.58% | -7.7% |
| Q4 2019 | $9,678,000 | +284.8% | 75,000 | +353.1% | 1.71% | +142.8% |
| Q2 2019 | $2,515,380 | -74.7% | 16,554 | -80.2% | 0.70% | -75.8% |
| Q1 2019 | $9,961,185 | +125.4% | 83,574 | +106.4% | 2.91% | +21.4% |
| Q4 2018 | $4,419,110 | -35.2% | 40,494 | -4.0% | 2.39% | -20.0% |
| Q3 2018 | $6,814,753 | +28.9% | 42,194 | +5.5% | 2.99% | +23.7% |
| Q2 2018 | $5,287,200 | – | 40,000 | – | 2.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |